| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/HMG/4.3.465 |
| P8608 | Fatcat ID | release_apvmd4q63je3dj4mr7xybt5ooq |
| P698 | PubMed publication ID | 7795604 |
| P2093 | author name string | R M Myers | |
| Y S Jou | |||
| P433 | issue | 3 | |
| P921 | main subject | Huntington's disease | Q190564 |
| P304 | page(s) | 465-469 | |
| P577 | publication date | 1995-03-01 | |
| P1433 | published in | Human Molecular Genetics | Q2720965 |
| P1476 | title | Evidence from antibody studies that the CAG repeat in the Huntington disease gene is expressed in the protein | |
| P478 | volume | 4 |
| Q28594336 | A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice |
| Q41084183 | Aberrant processing of the Fugu HD (FrHD) mRNA in mouse cells and in transgenic mice |
| Q39689805 | An upstream open reading frame impedes translation of the huntingtin gene |
| Q40859417 | Analysis of the subcellular localization of huntingtin with a set of rabbit polyclonal antibodies in cultured mammalian cells of neuronal origin: comparison with the distribution of huntingtin in Huntington's disease autopsy brain |
| Q45296558 | Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. |
| Q31987643 | Characterization of the Huntington's disease (HD) gene homologue in the zebrafish Danio rerio. |
| Q41182414 | Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract |
| Q29615357 | Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice |
| Q28246858 | Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation |
| Q45291767 | Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. |
| Q28594526 | Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion |
| Q24311567 | Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme |
| Q41521368 | Huntington disease: Advances in molecular and cell biology |
| Q41170305 | Huntington disease: new insights into the relationship between CAG expansion and disease |
| Q41527116 | Huntington's Disease and Dentatorubral‐Pallidoluysian Atrophy: Proteins, Pathogenesis and Pathology |
| Q45295496 | Huntington's disease gene product, huntingtin, associates with microtubules in vitro |
| Q26830039 | Huntington's disease: the past, present, and future search for disease modifiers |
| Q28506834 | Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue |
| Q42992139 | Isolation and characterization of the rat huntingtin promoter. |
| Q30640638 | Localization of rabbit huntingtin using a new panel of monoclonal antibodies |
| Q38173380 | Neuroprotective function of 14-3-3 proteins in neurodegeneration |
| Q48291079 | Pathogenesis of neurodegenerative diseases associated with expanded glutamine repeats: new answers, new questions. |
| Q45296540 | Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. |
| Q33650539 | Recent advances in understanding the pathogenesis of Huntington's disease |
| Q41527072 | The CAG/polyglutamine tract diseases: gene products and molecular pathogenesis |
| Q35212462 | Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease |
| Q41682897 | Transgenic mouse models of neurodegenerative disease caused by CAG/polyglutamine expansions |
| Q36826440 | Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length |
| Q45298027 | mRNAs encoding a von Ebner's-like protein and the Huntington disease protein are induced in rat male germ cells by Sertoli cells |
Search more.